Drugs giant AstraZeneca has revealed plans to overhaul its US listing, but stressed it will keep its headquarters in the UK and remain on the London market. Cambridge-based AstraZeneca is set to ...

WILMINGTON, Del., June 24, 2026--(BUSINESS WIRE)--AstraZeneca and YMCA of the USA (Y-USA) announced today at the Aspen Ideas: Health conference, a five-year partnership focused on strengthening cancer ...

The drug, known as camizestrant, can be used in combination with other cancer medicines in patients who have a genetically driven form of metastatic breast cancer. AstraZeneca said camizestrant, which ...

AstraZeneca has launched an online direct-to-consumer (DTC) medicine platform in the US, joining a growing list of companies opting for the model in a bid to cut drug prices amid pressure from ...

Add Yahoo as a preferred source to see more of our stories on Google. AstraZeneca has pulled Andexxa AstraZeneca has pulled its anticoagulant therapy, Andexxa (recombinant coagulation factor Xa), from ...

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) offers the richest run of drug news in the pharmaceuticals sector over the next 18 months, according to JP Morgan, which sees the coming wave of trial results as ...

Proposed $400bn tie-up with Bristol Myers Squibb would create world’s fourth-largest drugmaker but analysts question rationale ...

AstraZeneca (AZN) is shifting its focus to the US, calling itself an "American company" on Tuesday as it ramps up manufacturing and proposes price cuts for the US market. CEO Pascal Soriot told ...

CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the ...

AstraZeneca still trades at a premium valuation, but several factors limit its upside potential in the next visible period. There are three negative takeaways from China. IRA could also significantly ...